These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 18496432)
1. Generalized granuloma annulare as an initial manifestation of chronic myelomonocytic leukemia: a report of 2 cases. Hinckley MR; Walsh SN; Molnár I; Sheehan DJ; Sangueza OP; Yosipovitch G Am J Dermatopathol; 2008 Jun; 30(3):274-7. PubMed ID: 18496432 [TBL] [Abstract][Full Text] [Related]
2. Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders. Niscola P; Siniscalchi A; Tendas A; Scaramucci L; Fratoni S; de Fabritiis P; Caravita T Ann Hematol; 2015 Oct; 94(10):1753-4. PubMed ID: 26088814 [No Abstract] [Full Text] [Related]
3. Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: a case series and literature review. Thorpe M; Montalvão A; Pierdomenico F; Moita F; Almeida A Leuk Res; 2012 Aug; 36(8):1071-3. PubMed ID: 22607959 [TBL] [Abstract][Full Text] [Related]
5. A rare case of acquired haemophilia in a patient with chronic myelomonocytic leukaemia successfully treated with decitabine. Shah D; Kumar R; Gaikazian S Haemophilia; 2014 Jan; 20(1):e92-4. PubMed ID: 24261579 [No Abstract] [Full Text] [Related]
7. [Treatment of two chronic myelomonocytic leukemia patients with Decitabine]. Wang L; Wang HX; Zhao J Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):497. PubMed ID: 22213878 [No Abstract] [Full Text] [Related]
9. Generalized granuloma annulare in a patient with myelocytic leukemia and chronic hepatitis B virus infection. Aşkin U; Durdu M; Senel E Indian J Dermatol Venereol Leprol; 2009; 75(3):287-9. PubMed ID: 19439883 [TBL] [Abstract][Full Text] [Related]
10. Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia. Aribi A; Borthakur G; Ravandi F; Shan J; Davisson J; Cortes J; Kantarjian H Cancer; 2007 Feb; 109(4):713-7. PubMed ID: 17219444 [TBL] [Abstract][Full Text] [Related]
11. Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far? Breccia M; Voso MT; Alimena G Leuk Res; 2013 Feb; 37(2):204-5. PubMed ID: 23174191 [No Abstract] [Full Text] [Related]
12. Leukemia cutis in a patient with chronic myelomonocytic leukemia. Claßen A; Kitz J; Perske C; Overbeck T; Bertsch HP; Schön MP; Lippert U J Dtsch Dermatol Ges; 2018 Jan; 16(1):81-83. PubMed ID: 29288601 [No Abstract] [Full Text] [Related]
13. Clearance of generalized papular umbilicated granuloma annulare in a child with bath PUVA therapy. Batchelor R; Clark S Pediatr Dermatol; 2006; 23(1):72-4. PubMed ID: 16445418 [TBL] [Abstract][Full Text] [Related]
14. Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine. Hilmi M; Bally C; Burns R; Lorillon G; Bergeron A; Fenaux P; Ades L Ann Hematol; 2018 Mar; 97(3):541-542. PubMed ID: 29170809 [No Abstract] [Full Text] [Related]
16. [Isolated factor X deficiency in chronic myelomonocytic leukemia: Report of one case]. Zelada J; Cantó G; Berkovits A; Diocares G; López A Rev Med Chil; 2015 Nov; 143(11):1490-3. PubMed ID: 26757875 [TBL] [Abstract][Full Text] [Related]
17. Granuloma annulare as first clinical manifestation of diabetes mellitus in children: a case report. Spicuzza L; Salafia S; Capizzi A; Vitaliti G; Rotolo N; Leonardi S; La Rosa M Diabetes Res Clin Pract; 2012 Mar; 95(3):e55-7. PubMed ID: 22154372 [TBL] [Abstract][Full Text] [Related]
18. Wolf isotopic response manifesting as postherpetic granuloma annulare: a case series. Kapoor R; Piris A; Saavedra AP; Duncan LM; Nazarian RM Arch Pathol Lab Med; 2013 Feb; 137(2):255-8. PubMed ID: 23368868 [TBL] [Abstract][Full Text] [Related]
19. Activity of azacitidine in chronic myelomonocytic leukemia. Costa R; Abdulhaq H; Haq B; Shadduck RK; Latsko J; Zenati M; Atem FD; Rossetti JM; Sahovic EA; Lister J Cancer; 2011 Jun; 117(12):2690-6. PubMed ID: 21656746 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment. Yi JH; Huh J; Kim HJ; Kim SH; Kim SH; Kim KH; Do YR; Mun YC; Kim H; Kim MK; Kim HJ; Kim T; Kim DD Ann Hematol; 2013 Apr; 92(4):459-69. PubMed ID: 23262795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]